153 Relationship between micro RNA-145 and vascular smooth muscle cell senescence in diabetes. (June 2018)
- Record Type:
- Journal Article
- Title:
- 153 Relationship between micro RNA-145 and vascular smooth muscle cell senescence in diabetes. (June 2018)
- Main Title:
- 153 Relationship between micro RNA-145 and vascular smooth muscle cell senescence in diabetes
- Authors:
- Hemmings, Karen
Riches-Suman, Kirsten
Turner, Neil
Karen, Porter
O'Regan, David - Abstract:
- Abstract : Introduction: Saphenous vein (SV) graft failure after coronary bypass surgery is a significant problem in Type 2 diabetic (T2DM) patients, characterised by aberrant smooth muscle cell (SMC) remodelling. SV-SMC cultured from diabetic patients express elevated levels of microRNA-145, exhibit distinct morphology, impaired proliferation and DNA damage. This study explored a potential relationship between miR-145, DNA damage response signalling (DDR) and SV-SMC senescence. Methods: Using native human non-diabetic (ND) and T2DM-SMC, DDR signalling proteins (ATM, ATR, p21) were measured (real-time PCR) and subsequently quantified in ND cells overexpressing miR-145 (premiR-145 transfection). Conditioned medium (CM) from miR-145 overexpressing cells was analysed by ELISA for indicators of a senescence associated secretory phenotype (SASP) and to explore intracellular signalling (immunoblotting) in naïve ND-SMC. The effect of siRNA knockdown or pharmacological inhibition of ATM/ATR on cell proliferation was also explored (cell counting). Results: Increased expression of ATM, ATR and p21 was observed in T2DM-SMC relative to ND-SMC (n=8, p<0.05). MiR-145 overexpression increased ATR (n=7, p<0.01), and a trend to increased p21 was observed. Secretion of IL-6, IL-8 and MCP-1 was increased by 1.5, 2.0 and 5.5-fold, respectively (n=8, p<0.01) in miR-145-overexpressing cells; this CM induced persistent (≥96h) p38α phosphorylation in naïve cells. Pharmacological inhibition orAbstract : Introduction: Saphenous vein (SV) graft failure after coronary bypass surgery is a significant problem in Type 2 diabetic (T2DM) patients, characterised by aberrant smooth muscle cell (SMC) remodelling. SV-SMC cultured from diabetic patients express elevated levels of microRNA-145, exhibit distinct morphology, impaired proliferation and DNA damage. This study explored a potential relationship between miR-145, DNA damage response signalling (DDR) and SV-SMC senescence. Methods: Using native human non-diabetic (ND) and T2DM-SMC, DDR signalling proteins (ATM, ATR, p21) were measured (real-time PCR) and subsequently quantified in ND cells overexpressing miR-145 (premiR-145 transfection). Conditioned medium (CM) from miR-145 overexpressing cells was analysed by ELISA for indicators of a senescence associated secretory phenotype (SASP) and to explore intracellular signalling (immunoblotting) in naïve ND-SMC. The effect of siRNA knockdown or pharmacological inhibition of ATM/ATR on cell proliferation was also explored (cell counting). Results: Increased expression of ATM, ATR and p21 was observed in T2DM-SMC relative to ND-SMC (n=8, p<0.05). MiR-145 overexpression increased ATR (n=7, p<0.01), and a trend to increased p21 was observed. Secretion of IL-6, IL-8 and MCP-1 was increased by 1.5, 2.0 and 5.5-fold, respectively (n=8, p<0.01) in miR-145-overexpressing cells; this CM induced persistent (≥96h) p38α phosphorylation in naïve cells. Pharmacological inhibition or gene-silencing of ATR, but not ATM significantly inhibited cell proliferation (n=4, p<0.05). Conclusion: Aberrant expression of DDR proteins in T2DM-SMC can be mimicked, at least partially by miR-145 overexpression. MiR-145 drives a SASP, resulting in chronic p-38 phosphorylation. MiR-145 holds potential as a therapeutic target to ameliorate SMC senescence. … (more)
- Is Part Of:
- Heart. Volume 104(2018)Supplement 6
- Journal:
- Heart
- Issue:
- Volume 104(2018)Supplement 6
- Issue Display:
- Volume 104, Issue 6 (2018)
- Year:
- 2018
- Volume:
- 104
- Issue:
- 6
- Issue Sort Value:
- 2018-0104-0006-0000
- Page Start:
- A108
- Page End:
- A109
- Publication Date:
- 2018-06
- Subjects:
- vascular smooth muscle cell -- diabetes -- senescence
Heart -- Diseases -- Treatment -- Periodicals
Cardiology -- Periodicals
616.12 - Journal URLs:
- http://www.bmj.com/archive ↗
http://heart.bmj.com ↗
http://www.heartjnl.com ↗ - DOI:
- 10.1136/heartjnl-2018-BCS.149 ↗
- Languages:
- English
- ISSNs:
- 1355-6037
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19680.xml